Samuel J Moed's Net Worth
$6.54 Million
Who is Samuel J Moed?
Samuel J Moed has an estimated net worth of $6.54 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, and BiondVax Pharmaceuticals Ltd..
SEC CIK
Samuel J Moed's CIK is 0001561017
Past Insider Trading and Trends
2013 was Samuel J Moed's most active year for acquiring shares with 19 total transactions. Samuel J Moed's most active month to acquire stocks was the month of February. 2013 was Samuel J Moed's most active year for disposing of shares, totalling 16 transactions. Samuel J Moed's most active month to dispose stocks was the month of February. 2015 saw Samuel J Moed paying a total of $618,547.32 for 62,060.782 shares, this is the most they've acquired in one year. In 2013 Samuel J Moed cashed out on 149,204 shares for a total of $3,127,239.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6
SVP, Strat Plan & Analysis
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.87% | -591.00 |
$66.67 | -$39,401.97 | 31.01K |
Mar 13
| |||
Form 4
| -22.06% | -8.94K |
$65.80 | -$779,695.46 | 31.61K |
Mar 10
| |||
Form 4
| +2.45% | 969 |
$65.12 | -$68,050.40 | 40.55K |
Mar 6
| |||
Form 4
| +11.15% | 3.97K |
$62.30 | -$266,581.70 | 39.58K |
Mar 2
| |||
Form 4
| +3.28% | 1.13K |
$62.30 | -$75,881.40 | 35.61K |
Mar 2
| |||
Form 4
| -10.11% | -3.88K |
$59.26 | -$229,932.68 | 34.48K |
Feb 12
| |||
Form 4
| +20.25% | 6.46K |
$41.15 | -$673,440.29 | 38.36K |
Feb 6
| |||
Form 4
| -5.90% | -2.00K |
—
|
—
| 31.9K |
Jul 31
| |||
Form 4
| -15.25% | -6.10K |
$38.17 | -$739,290.64 | 33.9K |
Jul 28
| |||
Form 4
| +6.40% | 2.41K |
$49.52 | -$128,405.36 | 40K |
May 1
| |||
Form 4
| +2.23% | 820 |
$56.14 | -$49,683.90 | 37.6K |
Mar 10
| |||
Form 4
| +2.73% | 977 |
$55.56 | -$43,003.44 | 36.78K |
Mar 6
| |||
Form 4
| +45.01% | 11.11K |
$53.49 | -$352,445.61 | 35.8K |
Mar 3
| |||
Form 4
| +5.12% | 1.2K |
$36.54 | -$1,246,314.24 | 24.69K |
Jun 4
| |||
Form 4
| +13.16% | 2.73K |
$39.72 | -$90,124.68 | 23.49K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +90.70% | 9.87K |
$37.53 | -$220,113.45 | 20.75K |
Mar 7
| |||
Form 4
| +12.68% | 1.23K |
$37.15 | -$26,413.65 | 10.88K |
Mar 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BiondVax Pharmaceuticals Ltd. (SCNI) Snapshot price: $3.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |